#Japan #Tokyo #TROMATZ #Proxy Healthcare #biobrush

TROMATZ: A New Era in Oral Care in Japan

In an exciting announcement, Nihon TROMATZ Corporation has been founded in Tokyo on November 11, 2025. This company marks the entry of the innovative TROMATZ brand into the Japanese market, specializing in biocurrent technology that has been creating waves in the US and Korea. The standout product, the TROMATZ biobrush, will be available for sale starting January 11, 2026. This move comes on the heels of TROMATZ’s impressive performance at prestigious competitions, including finishing as the runner-up among 7,300 companies in a contest sponsored by the Samsung Group.

About Nihon TROMATZ Corporation

Nihon TROMATZ Corporation serves as the domestic partner and exclusive distributor for Proxy Healthcare, the startup behind the TROMATZ brand. With over 160 patents, the Proxy Healthcare company has pioneered technology that can separate and remove bacterial biofilms using specific frequencies of biocurrent. The Japanese arm aims to utilize these cutting-edge techniques to combat periodontal disease.

Strategic Partnerships and Future Expansion

Not only is TROMATZ focusing on oral health, but it also has collaborations, such as with LG to develop microcurrent facial devices that suppress inflammation caused by bacteria. Furthermore, the company is actively conducting joint experiments with the navy to explore electric separation methods for barnacles.

The company's CEO, Koji Kanbara, is set to leverage his background in healthcare distribution to oversee the introduction of the TROMATZ biobrush to the Japanese market. The launch will coincide with TechGALA Japan, a global event in Nagoya that showcases startups and the latest in technology from January 27 to 29, 2026. This event will serve as a platform to highlight the groundbreaking capabilities of the TROMATZ product line.

What Makes the TROMATZ Biobrush Unique?

Previously, 10,000 units of the biobrush were released in Japan under the PLAQLES brand two years ago. With a significant upgrade targeting periodontal care, the TROMATZ biobrush now utilizes biocurrent technology to tackle dental plaque at its source—bacterial biofilms in the oral cavity.

This brush not only focuses on traditional cleaning tasks but also addresses hard-to-reach areas, such as periodontal pockets, the gaps between teeth and gums, through scientific, technological means. With bacteria constantly thriving in the oral environment, the potential for tooth decay, periodontal disease, halitosis, and even systemic health issues rises. The TROMATZ biobrush transcends conventional tooth brushing by providing comprehensive oral care.

TROMATZ Biobrush Details

• - Type: Clinical Grade Biobrush
• - Price: ¥39,800 (excluding tax)
• - Included: Main device + two replacement brushes (standard and for gum/tongue cleaning)
• - Launch Date: January 11, 2026

CEO Profile: Koji Kanbara

Born in 1977 in Yokohama, Kanagawa, Koji Kanbara began his professional journey in 2000 with the Mitsui Group trading company. He progressed through roles in management planning and the president's office at a major retail corporate before founding Nihon Oribak in 2010. Under his leadership, his group operates 130 treatment centers in Higashi Ginza. Currently, he holds positions as an external director at Proxy Healthcare and CEO at Nihon TROMATZ.

Company Overview

• - Company Name: Nihon TROMATZ Corporation
• - Headquarters: 20F Ariake Park Building, 3-7-11 Ariake, Koto-ku, Tokyo
• - CEO: Koji Kanbara
• - CTO: Y.W. Kim (CEO of Proxy Healthcare/Ph.D. in Engineering)
• - Business Focus: Expansion of the TROMATZ brand in Japan
• - Established: November 11, 2025

With the advent of the TROMATZ biobrush, Japan is set to embrace a transformative era in oral health care, centered around advanced biocurrents and a scientific approach to tackling oral hygiene challenges.